Armistice Capital’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.07M Sell
1,096,000
-104,000
-9% -$688K 0.09% 121
2026
Q1
$7.42M Sell
1,200,000
-64,000
-5% -$395K 0.13% 105
2025
Q4
$8.49M Buy
1,264,000
+400,000
+46% +$3M 0.1% 108
2025
Q3
$7.06M Buy
864,000
+200,000
+30% +$1.5M 0.1% 97
2025
Q2
$4.67M Buy
+664,000
New +$4.47M 0.08% 102

Other funds holding INGN

Armistice Capital's INGN Position: Q2 2026 in Review

Armistice Capital reduced its Inogen (INGN) stake by 8.7% in Q2 2026, selling an estimated $688K and leaving 1,096,000 shares worth $7.07M. The position accounts for 0.09% of the portfolio, ranked #121.

Armistice Capital first reported a position in INGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.49M in Q4 2025. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Armistice Capital held 1,096,000 shares of Inogen worth $7.07M as of Q2 2026.
  • Armistice Capital sold 104,000 Inogen shares in Q2 2026, an estimated $688K.
  • Inogen made up 0.09% of Armistice Capital's portfolio in Q2 2026, its #121 holding.
  • Armistice Capital first reported a position in Inogen in Q2 2025 and has held it in 5 quarters since.
  • Armistice Capital's Inogen position peaked at $8.49M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.